Jacobi Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-116
| Closed | -$1K | – | 1230 |
|
|
2021
Q3 | $1K | Hold |
116
| – | – | ﹤0.01% | 1414 |
|
|
2021
Q2 | $1K | Sell |
116
-78
| -40% | -$672 | ﹤0.01% | 1360 |
|
|
2021
Q1 | $2K | Hold |
194
| – | – | ﹤0.01% | 1261 |
|
|
2020
Q4 | $2K | Sell |
194
-1,200
| -86% | -$12.4K | ﹤0.01% | 1180 |
|
|
2020
Q3 | $13K | Hold |
1,394
| – | – | ﹤0.01% | 768 |
|
|
2020
Q2 | $17K | Hold |
1,394
| – | – | ﹤0.01% | 680 |
|
|
2020
Q1 | $13K | Sell |
1,394
-100
| -7% | -$933 | ﹤0.01% | 664 |
|
|
2019
Q4 | $15K | Hold |
1,494
| – | – | ﹤0.01% | 686 |
|
|
2019
Q3 | $10K | Hold |
1,494
| – | – | ﹤0.01% | 734 |
|
|
2019
Q2 | $14K | Hold |
1,494
| – | – | ﹤0.01% | 692 |
|
|
2019
Q1 | $23K | Sell |
1,494
-500
| -25% | -$7.7K | 0.01% | 548 |
|
|
2018
Q4 | $31K | Hold |
1,994
| – | – | 0.01% | 459 |
|
|
2018
Q3 | $43K | Buy |
1,994
+350
| +21% | +$7.55K | 0.01% | 443 |
|
|
2018
Q2 | $40K | Hold |
1,644
| – | – | 0.01% | 449 |
|
|
2018
Q1 | $28K | Hold |
1,644
| – | – | 0.01% | 498 |
|
|
2017
Q4 | $31K | Hold |
1,644
| – | – | 0.01% | 464 |
|
|
2017
Q3 | $26K | Sell |
1,644
-3,617
| -69% | -$57.2K | 0.01% | 460 |
|
|
2017
Q2 | $164K | Hold |
5,261
| – | – | 0.06% | 146 |
|
|
2017
Q1 | $168K | Buy |
5,261
+1,328
| +34% | +$42.4K | 0.09% | 110 |
|
|
2016
Q4 | $135K | Sell |
3,933
-877
| -18% | -$30.1K | 0.08% | 120 |
|
|
2016
Q3 | $218K | Sell |
4,810
-405
| -8% | -$18.4K | 0.1% | 84 |
|
|
2016
Q2 | $262K | Buy |
+5,215
| New | +$262K | 0.13% | 70 |
|